• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经体外共孵育 P 糖蛋白抑制剂 R(+)-维拉帕米后,对三氯苯达唑(TCBZ)耐药的肝片形吸虫分离株对 TCBZ 的敏感性增加。

Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.

机构信息

Parasite Therapeutics Research Group, School of Biological Sciences, Medical Biology Centre, The Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland.

出版信息

Parasitology. 2013 Sep;140(10):1287-303. doi: 10.1017/S0031182013000759. Epub 2013 Jun 12.

DOI:10.1017/S0031182013000759
PMID:23756576
Abstract

A study was carried out to investigate whether the action of triclabendazole sulphoxide (TCBZ.SO) against the liver fluke, Fasciola hepatica is altered by inhibition of P-glycoprotein (Pgp)-linked drug efflux pumps. The Oberon TCBZ-resistant and Cullompton TCBZ-susceptible fluke isolates were used for this in vitro study and the Pgp inhibitor selected was R(+)-verapamil [R(+)-VPL]. For experiments with the Oberon isolate, flukes were incubated for 24 h with either R(+)-VPL (1×10-4 m) on its own, TCBZ.SO (15 μg mL-1) alone, a combination of R(+)-VPL (1×10-4 m) plus TCBZ.SO (15 μg mL-1), TCBZ.SO (50 μg mL-1) on its own, or a combination of TCBZ.SO (50 μg mL-1) plus R(+)-VPL (1×10-4 m). They were also incubated in TCBZ.SO (50 μg mL-1) alone or in combination with R(+)-VPL (1×10-4 m) until they became inactive; and in TCBZ.SO (50 μg mL-1) alone for a time to match that of the combination inactivity time. Flukes from the Cullompton isolate were treated with either TCBZ.SO (50 μg mL-1) alone or in combination with R(+)-VPL (1×10-4 m) until they became inactive, or with TCBZ.SO (50 μg mL-1) alone time-matched to the combination inactivity time. Morphological changes resulting from drug treatment and following Pgp inhibition were assessed by means of scanning electron microscopy. Incubation in R(+)-VPL alone had a minimal effect on either isolate. TCBZ.SO treatment had a relatively greater impact on the TCBZ-susceptible Cullompton isolate. When R(+)-VPL was combined with TCBZ.SO in the incubation medium, however, the surface disruption to both isolates was more severe than that seen after TCBZ.SO treatment alone; also, the time taken to reach inactivity was shorter. More significantly, though, the potentiation of drug activity was greater in the Oberon isolate; also, it was more distinct at the higher concentration of TCBZ.SO. So, the Oberon isolate appears to be particularly sensitive to efflux pump inhibition. The results of this study suggest that enhanced drug efflux in the Oberon isolate may be involved in the mechanism of resistance to TCBZ.

摘要

一项研究旨在探讨三氯苯达唑亚砜(TCBZ.SO)对肝片吸虫(Fasciola hepatica)的作用是否因 P 糖蛋白(Pgp)相关药物外排泵的抑制而改变。本体外研究采用了奥伯龙 TCBZ 耐药株和卡伦顿 TCBZ 敏感株,并选择了 Pgp 抑制剂 R(+)-维拉帕米[R(+)-VPL]。对于奥伯龙株的实验,将吸虫在单独的 R(+)-VPL(1×10-4 m)、单独的 TCBZ.SO(15 μg mL-1)、R(+)-VPL(1×10-4 m)加 TCBZ.SO(15 μg mL-1)、单独的 TCBZ.SO(50 μg mL-1)或 TCBZ.SO(50 μg mL-1)加 R(+)-VPL(1×10-4 m)中孵育 24 小时。它们还在 TCBZ.SO(50 μg mL-1)单独或与 R(+)-VPL(1×10-4 m)联合孵育直至失活;并在 TCBZ.SO(50 μg mL-1)中单独孵育一段时间以匹配联合失活时间。来自卡伦顿株的吸虫用 TCBZ.SO(50 μg mL-1)单独或与 R(+)-VPL(1×10-4 m)联合孵育直至失活,或与单独的 TCBZ.SO(50 μg mL-1)孵育时间与联合失活时间相匹配。通过扫描电子显微镜评估药物处理和 Pgp 抑制后产生的形态变化。单独孵育 R(+)-VPL 对两种株系的影响都很小。TCBZ.SO 处理对 TCBZ 敏感的卡伦顿株系的影响相对较大。然而,当 R(+)-VPL 与 TCBZ.SO 一起加入孵育培养基中时,与 TCBZ.SO 单独处理相比,两种株系的表面破坏更为严重,达到失活所需的时间也更短。更重要的是,奥伯龙株系的药物活性增强更为明显;此外,在较高的 TCBZ.SO 浓度下更为明显。因此,奥伯龙株系似乎对外排泵抑制特别敏感。这项研究的结果表明,奥伯龙株系中药物外排的增强可能参与了对 TCBZ 的耐药机制。

相似文献

1
Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.经体外共孵育 P 糖蛋白抑制剂 R(+)-维拉帕米后,对三氯苯达唑(TCBZ)耐药的肝片形吸虫分离株对 TCBZ 的敏感性增加。
Parasitology. 2013 Sep;140(10):1287-303. doi: 10.1017/S0031182013000759. Epub 2013 Jun 12.
2
Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.P-糖蛋白抑制剂R(+)-维拉帕米对三氯苯达唑耐药肝片吸虫分离株药物敏感性的影响
Vet Parasitol. 2013 Jul 1;195(1-2):72-86. doi: 10.1016/j.vetpar.2013.03.007. Epub 2013 Mar 22.
3
Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.经 P 糖蛋白抑制剂 R(+)-维拉帕米共孵育后,三氯苯达唑(TCBZ)对一株 TCBZ 耐药的肝片形吸虫分离株的体外活性增强。
Exp Parasitol. 2013 Nov;135(3):642-53. doi: 10.1016/j.exppara.2013.09.015. Epub 2013 Oct 1.
4
Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor.在体外与P-糖蛋白抑制剂孵育后,三氯苯达唑(TCBZ)对肝片吸虫耐TCBZ分离株的卵黄发生和精子发生的破坏作用
Parasitology. 2014 Jul;141(8):1064-79. doi: 10.1017/S0031182014000377.
5
Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.酮康唑体外抑制三氯苯达唑代谢增加了对三氯苯达唑耐药华支睾吸虫虫体被膜的破坏。
Parasitol Res. 2011 Oct;109(4):981-95. doi: 10.1007/s00436-011-2304-9. Epub 2011 Mar 26.
6
Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.代谢抑制剂甲巯咪唑对三氯苯达唑耐药肝片吸虫分离株药物敏感性的影响。
Parasitology. 2009 Feb;136(2):183-92. doi: 10.1017/S0031182008005222. Epub 2008 Dec 12.
7
Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.甲巯咪唑增强三氯苯达唑亚砜对肝片形吸虫耐药分离株引起的皮层破坏作用。
Parasitol Res. 2010 May;106(6):1351-63. doi: 10.1007/s00436-010-1806-1. Epub 2010 Mar 25.
8
Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.酮康唑作为代谢抑制剂与三氯苯达唑联合应用对体内三氯苯达唑耐药华支睾吸虫分离株的增效作用。
Vet Parasitol. 2012 Feb 28;184(1):37-47. doi: 10.1016/j.vetpar.2011.08.006. Epub 2011 Aug 6.
9
Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole.使用代谢抑制剂酮康唑增强对肝片形吸虫三氯苯达唑耐药分离株的药物敏感性。
Parasitol Res. 2010 Jul;107(2):337-53. doi: 10.1007/s00436-010-1866-2. Epub 2010 May 30.
10
Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.增效醚增强三氯苯达唑对三氯苯达唑耐药肝片形吸虫的作用。
Parasitology. 2011 Feb;138(2):224-36. doi: 10.1017/S0031182010001125. Epub 2010 Oct 15.

引用本文的文献

1
Hepatobiliary fascioliasis: A neglected re-emerging threat, its diagnostic and management challenges.肝胆片形吸虫病:一种被忽视的再度出现的威胁,及其诊断和管理挑战。
World J Gastrointest Pathophysiol. 2025 Jun 22;16(2):107599. doi: 10.4291/wjgp.v16.i2.107599.
2
Independent origins and non-parallel selection signatures of triclabendazole resistance in Fasciola hepatica.肝片吸虫中三氯苯达唑抗性的独立起源和非平行选择特征
Nat Commun. 2025 Mar 27;16(1):2996. doi: 10.1038/s41467-025-57796-5.
3
A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance.
一个主要基因座赋予肝片形吸虫对三氯苯达唑的耐药性,并表现出显性遗传。
PLoS Pathog. 2023 Jan 26;19(1):e1011081. doi: 10.1371/journal.ppat.1011081. eCollection 2023 Jan.
4
The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Are Associated with Geographic, Seasonal, and Morphometric Variations.田间分离株对三氯苯达唑亚砜敏感性模式的差异与地理、季节和形态测量变异有关。
Pathogens. 2022 May 28;11(6):625. doi: 10.3390/pathogens11060625.
5
Drug resistance in liver flukes.肝吸虫耐药性。
Int J Parasitol Drugs Drug Resist. 2020 Apr;12:39-59. doi: 10.1016/j.ijpddr.2019.11.003. Epub 2020 Jan 10.
6
Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt.评价在埃及上埃及地区一次由三氯苯达唑失败引起的人类片形吸虫病爆发中使用硝唑尼特治疗的效果。
PLoS Negl Trop Dis. 2019 Sep 25;13(9):e0007779. doi: 10.1371/journal.pntd.0007779. eCollection 2019 Sep.
7
Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions.在寻找抗寄生虫药物抗性标记物及描述药物/受体相互作用方面,候选基因法和全基因组法的最新进展。
Int J Parasitol Drugs Drug Resist. 2014 Aug 13;4(3):164-84. doi: 10.1016/j.ijpddr.2014.07.007. eCollection 2014 Dec.
8
Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells.巨大溶酶体作为肝癌细胞化疗耐药的一种机制
PLoS One. 2014 Dec 10;9(12):e114787. doi: 10.1371/journal.pone.0114787. eCollection 2014.